Well #1: Marker
Well #2: Sample #0 (A)
Well #3: Sample #1 (A)
Well #4: Sample #2 (Flow Through)
Well #5: Sample #3 (Wash)
Well #6: Sample #4 (Elution #1)
Well #7: Sample #5 (Elution #2)
FPLC
- After running the process, it was found that fractions #31-38 and #39-46 were the best ones for in assay and inhibition.
I later would concentrate each set of fractions for use.
181 GGTGAAAAACTCAACCGCTTCCGTGACATCCAATGCCGTCGTCAGACCGCA ccactttttga GGCAGCAGTCTGGCGTCAAGCACGC <--- 4 G E K L N R F R D I Q C R R Q T A V R A
| | | | | | |
7 ---> 241 actacatccaggttggtaacactcgcaccatcgcctgccagtacccg CTAGACTTGCGCTTGATGTAGGTCCAACCATTGTG gggc <--- 6 D L N A N Y I Q V G N T R T I A C Q Y P
| | | | | | |
9 ---> 301 ctgcagtctcaac TGAAAACCGTACCCCGGTTCTG gacgtcagagttgaccttagagtgaaggcgtacgaccgacttttggcatggggcca <--- 8 L Q S Q L E S H F R M L A E N R T P V L
| | | | | | |
1 361 GCTGTGCTGGCGTCTTCTTCTGAGATCGCGAATCAGCG c GACTCTAGCGCTTAGTCGCAAAGCCATACGGCCTGATGAAG
A V L A S S S E I A N Q R F G M P D Y F
| | | | | | |
1 ---> 421 cgtcaatctggtacctacggttctatcaccgttgaatccaaaatgacccagcaggtcgg GCAGTTAGACCATGGATGC tactgggtcgtccagcca <--- 10 R Q S G T Y G S I T V E S K M T Q Q V G
| | | | | | |
13 ---> 481 GACATGTACACCCTGACCATCCGTGAAGCGGGTCAGAAA gacccactgccatagtaccgcctgtacatgtgggactggtag <--- 12 L G D G I M A D M Y T L T I R E A G Q K
| | | | | | |
15 ---> 541 ACCATCTCTGTTCCGGTTGTT aaaccgccgtttctagc GGTAGAGACAAGGCCAACAAGTGCAGCCATTGACCGGCCTAGTTTGGCGGCAAAGATCG <--- 1 T I S V P V V H V G N W P D Q T A V S S
| | | | | | |
601 gaggtcactaaagcgctcgcttctctggttgatcagactgcgg C gaccaactagtctgacgcctctggtttgcattgtac 4 E V T K A L A S L V D Q T A E T K R N M
| | | | | | |
17 ---> 661 TGAATCTAAAGGTTCCTCTGCCGTTGCGGACGACTCCAAACTGCGTCCAGTTATCCAC atacttagatttccaaggagacgg GACGCAGGTCAATAGGTG <--- 16 Y E S K G S S A V A D D S K L R P V I H
| | | | | | |
19 ---> 721 TG gcagctgatcggtgcgatgtgcatgaacgactct ACAGCGCGTCCACAACCAGCATGCCGCGTCGACTAGCCACGC <--- 18 C R A G V G R T A Q L I G A M C M N D S
FINAL SUMMARY FOR 1 SOLUTION -------------------------------------------------------------------------------- # Tm Len | Score TmRange Short Long #Olig #Repeat #Misprime
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pNIC-Bsa4 (Highest Conc. of pLIC)
Lane 4: PCR pNIC-Bsa4 (Medium Conc. of pLIC)
Lane 5: PCR pNIC-Bsa4 (Lowest Conc. of pLIC)
Lane 6: PCR pNIC-Bsa4 (No pLIC; Control)
PyMol Refresher
- View of the chains, active sites,and polar contacts in 2H2Q
- View of the chains, active sites,and polar contacts in 3CL9
- View of the chains, active sites,and polar contacts in 1U72
- Combination of the active sites for 1U72 & 3CL9, showing each of their polar contacts
- Four different chains involved in the protein 3HBB
- Comparison of both NAP (MTX) for the 1st chain in 3HBB
Lane 1: Skipped
Lane 2: 1 kb Ladder
Lane 3: Uncut pGBR-22
Lane 4: EcoRI, cut with pGBR-22 (Tube A)
Lane 5: PvuII, cut with pGBR-22 (Tube B)
Lane 6: EcoRI + PvuII, cut with pGBR-22 (Tube C)
PCR pGBR22 Gel Run
1st Attempt:
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pGBR-22 (Tube A), none shown
Lane 4: PCR pGBR-22 (Tube B), none shown
Lane 5: PCR pGBR-22 (Tube C), none shown
Lane 6: PCR pGBR-22 (Tube D), none shown
2nd Attempt:
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pGBR-22 (Tube A), none shown
Lane 4: PCR pGBR-22 (Tube B), none shown
Lane 5: PCR pGBR-22 (Tube C), none shown
Lane 6: PCR pGBR-22 (Tube D), none shown
3rd Attempt:
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pGBR-22 (Tube A)
Lane 4: PCR pGBR-22 (Tube B)
Lane 5: PCR pGBR-22 (Tube C)
Lane 6: PCR pGBR-22 (Tube D)
Week 1
Analyzing DNA Sequence
VDS4_M13R.. Original Sequence: `NNNNNNNNNNNTATNGNATACTCAAGCTATGCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCACTAGTGATTTTGATTGATTGAAGGAGAAATATCATGAGTGTGATCGCTAAACAAATGACCTACAAGGTTTATATGTCAGGCACGGTCAATGGACACTACTTTGAGGTCGAAGGCGATGGAAAAGGAAAGCCTTACGAGGGGGAGCAGACGGTAAAGCTCACTGTCACCAAGGGTGGACCTCTGCCATTTGCTTGGGATATTTTATCACCACTGTCTCAATACGGAAGCATACCATTCACCAAGTACCCTGAAGACATCCCTGATTATGTAAAGCAGTCATTCCCTGAGGGATATACATGGGAGAGGATCATGAACTTTGAAGATGGTGCAGTGTGTACTGTCAGCAATGATTCCAGCATCCAAGGCAACTGTTTCATCTACAATGTCAAAATCTCTGGTGTGAACTTTCCTCCCAATGGACCTGTTATGCAGAAGAAGACACAGGGCTGGGAACCCAACACTGAGCGTCTCTTTGCACGAGATGGAATGCTGATAGGAAACAACTTTATGGCTCTGAAGTTGGAAGGAGGTGGTTACTATTTGTGTGAATTCAAATCTACTTACAAGGCAAAGAAGCCTGTGAGGATGCCAGGGTATCACTATGTTGACCGCAAACTGGATGTAACCAGTCACAACAAGGATTACACATTTGTTGAGCAGTGTGAAATATCCATTGCACGCCACTCTTTGCTCGGTCATCACCATCACCATCACTAAAATCCCGCGGCCATGGCGGCCGGGAGCATGCGACGTCGGGCCCAATTCGCCCTATAGTGAGTCGTATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAANAGGCCCGCACCGATCGCCCTTCCCACAGTTGCGCAGCCTGATGGCNATGGACGCNNCCTGNANCGNCGCATTAGCNCGGCNGGNNNGNGNNCNCGCAGCGNGACNCTACANTTNCNGCNNCNANCNNNNNCNTTCNNTTNTNCNNNTNNNNNNNNNNNNNNNTTNCCGNNAGNTNNAANNGGGGNNNNNNNNNATNNGNTNNNNNNNNNNCCAAANTGNNNGNNNNGNNNNNNNNGNNNNNNNNNNNNNNNNNNNNNNNGANCNNNNNNNNNNNNANNNNNNNNNNNCNNNNNAANNNNNCCNNTNNN
VDS_M13R.. Without the N’s: TATNGNATACTCAAGCTATGCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCACTAGTGATTTTGATTGATTGAAGGAGAAATATCATGAGTGTGATCGCTAAACAAATGACCTACAAGGTTTATATGTCAGGCACGGTCAATGGACACTACTTTGAGGTCGAAGGCGATGGAAAAGGAAAGCCTTACGAGGGGGAGCAGACGGTAAAGCTCACTGTCACCAAGGGTGGACCTCTGCCATTTGCTTGGGATATTTTATCACCACTGTCTCAATACGGAAGCATACCATTCACCAAGTACCCTGAAGACATCCCTGATTATGTAAAGCAGTCATTCCCTGAGGGATATACATGGGAGAGGATCATGAACTTTGAAGATGGTGCAGTGTGTACTGTCAGCAATGATTCCAGCATCCAAGGCAACTGTTTCATCTACAATGTCAAAATCTCTGGTGTGAACTTTCCTCCCAATGGACCTGTTATGCAGAAGAAGACACAGGGCTGGGAACCCAACACTGAGCGTCTCTTTGCACGAGATGGAATGCTGATAGGAAACAACTTTATGGCTCTGAAGTTGGAAGGAGGTGGTTACTATTTGTGTGAATTCAAATCTACTTACAAGGCAAAGAAGCCTGTGAGGATGCCAGGGTATCACTATGTTGACCGCAAACTGGATGTAACCAGTCACAACAAGGATTACACATTTGTTGAGCAGTGTGAAATATCCATTGCACGCCACTCTTTGCTCGGTCATCACCATCACCATCACTAAAATCCCGCGGCCATGGCGGCCGGGAGCATGCGACGTCGGGCCCAATTCGCCCTATAGTGAGTCGTATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAANAGGCCCGCACCGATCGCCCTTCCCACAGTTGCGCAGCCTGATGGCNATGGACGCNNCCTGNANCGNCGCATTAGCNCGGCNGGNNNGNGNNCNCGCAGCGNGACNCTACANTTNCNGCNNCNANCNNNNNCNTTCNNTTNTNCNNNT
Blast #1:
Blast #2:
Comparison to Known DNA:
Translation with the PurpleProteinCodingSequenceforBB.txt:
Chijioke's Research
Week 13 -
Protein Enzyme Assay
Absorbance taken @ 410 nm
Molecular Weight: 33512.8 kDa
1st Run (#39-46):
Initial Conc.- .4 mg/mL
A: .000
B: .570
C: 1.103
D: 1.003
E: .950
F: .581
G: .616
H: 1.405
2nd Run (#31-38):
Initial Conc.- .5 mg/mL
A: .000
B: .417
C: .238
D: .325
E: .252
F: .893
G: .617
H: .982
Week 12 -
YopH Virtual Screening
HF9 Library
- #1 best ligand (RH00719SC)
- #2 best ligand (BTB05187SC)
- #3 best ligand (DFP00065SC)
- #4 best ligand (HTS09290SC)
- #5 best ligand (BTB08339SC)
- #6 best ligand (JFD03976SC)
- #7 best ligand (RJF00101SC)
- #8 best ligand (BR00114SC)
- #9 best ligand (HTS11989SC)
- #10 best ligand (CD03598SC)
CB306 Library

- Top 5 Ligands found in library- #1 best ligand (7575772)
- #2 best ligand (5467784)
- #3 best ligand (7842136)
- #4 best ligand (7726180)
- #5 best ligand (6629394)
Week 11 -
Protein Characterization
Well #1: Marker
Well #2: Sample #0 (A)
Well #3: Sample #1 (A)
Well #4: Sample #2 (Flow Through)
Well #5: Sample #3 (Wash)
Well #6: Sample #4 (Elution #1)
Well #7: Sample #5 (Elution #2)
FPLC
- After running the process, it was found that fractions #31-38 and #39-46 were the best ones for in assay and inhibition.
I later would concentrate each set of fractions for use.
Week 10 -
Protein Purification
- Sample #3 (Flow Through)
- Sample #4 (Wash)
- Sample #5 (Elution #1)
- Sample #6 (Elution #2)
Week 9 -
Protein Expression
- Sample #0 (A & B)
- Sample #1 (A & B)
- Sample #2 [made from combination of A & B samples of #0 and #1]
Week 8 -
pNIC-Bsa4 Cloning
- YopH Master Plate
- pNIC-Bsa4 PCR Cloning Gel
- pNIC-Bsa4 Nanodrop Graph
- Sample 1
- Sample 2 (Take 1)
- Sample 2 (Take 2)
- Sample 3
- Sample 4 (Take 1)
- Sample 4 (Take 2)
- Sample 5 (Take 1)
- Sample 5 (Take 2)
- Sample 6 (Take 1)
- Sample 6 (Take 2)
- Sample 7 (Take 1)
- Sample 7 (Take 2)
- Sample 8 (Take 1)
- Sample 8 (Take 2)
Week 7 -
My samples for cloning were lost this week, so I needed to re-run the procedure again. No results were taken from this week.
Week 6 -
Chijioke - good job. Don't need to show so much of primer design. Maybe just show your final primers (oligos). --Dr. BPCR Primer Design for Yersinia pestis (YopH)
The oligonucleotide assembly is:
----------------------------------------------------------------
1 10 20 30 40 50 60
| | | | | | |
1 --->
1 ATGCGCGAACGCCCACACACCTCTGGTCACCACGGTGCCGGCGAAGCTCGCGCAACCGC
CGAGCGCGTTGGCGC
M R E R P H T S G H H G A G E A R A T A
| | | | | | |
3 --->
61 aggctcgtgccgaactgtcttctcgtctgacc
GGAAGATGGCAAAGGGGTATGCCAGGCCTCCGAGCACGGCTTGAC
<--- 2
P S T V S P Y G P E A R A E L S S R L T
| | | | | | |
5 --->
121 accctgcgtaataccctggcaccagcaa GCATGTGGT
atgggaccgtggtcgttggttgctgggcgcaatggacgttcgtacacca
T L R N T L A P A T N D P R Y L Q A C G
| | | | | | |
181 GGTGAAAAACTCAACCGCTTCCGTGACATCCAATGCCGTCGTCAGACCGCA
ccactttttga GGCAGCAGTCTGGCGTCAAGCACGC
<--- 4
G E K L N R F R D I Q C R R Q T A V R A
| | | | | | |
7 --->
241 actacatccaggttggtaacactcgcaccatcgcctgccagtacccg
CTAGACTTGCGCTTGATGTAGGTCCAACCATTGTG gggc
<--- 6
D L N A N Y I Q V G N T R T I A C Q Y P
| | | | | | |
9 --->
301 ctgcagtctcaac TGAAAACCGTACCCCGGTTCTG
gacgtcagagttgaccttagagtgaaggcgtacgaccgacttttggcatggggcca
<--- 8
L Q S Q L E S H F R M L A E N R T P V L
| | | | | | |
1
361 GCTGTGCTGGCGTCTTCTTCTGAGATCGCGAATCAGCG c
GACTCTAGCGCTTAGTCGCAAAGCCATACGGCCTGATGAAG
A V L A S S S E I A N Q R F G M P D Y F
| | | | | | |
1 --->
421 cgtcaatctggtacctacggttctatcaccgttgaatccaaaatgacccagcaggtcgg
GCAGTTAGACCATGGATGC tactgggtcgtccagcca
<--- 10
R Q S G T Y G S I T V E S K M T Q Q V G
| | | | | | |
13 --->
481 GACATGTACACCCTGACCATCCGTGAAGCGGGTCAGAAA
gacccactgccatagtaccgcctgtacatgtgggactggtag
<--- 12
L G D G I M A D M Y T L T I R E A G Q K
| | | | | | |
15 --->
541 ACCATCTCTGTTCCGGTTGTT aaaccgccgtttctagc
GGTAGAGACAAGGCCAACAAGTGCAGCCATTGACCGGCCTAGTTTGGCGGCAAAGATCG
<--- 1
T I S V P V V H V G N W P D Q T A V S S
| | | | | | |
601 gaggtcactaaagcgctcgcttctctggttgatcagactgcgg
C gaccaactagtctgacgcctctggtttgcattgtac
4
E V T K A L A S L V D Q T A E T K R N M
| | | | | | |
17 --->
661 TGAATCTAAAGGTTCCTCTGCCGTTGCGGACGACTCCAAACTGCGTCCAGTTATCCAC
atacttagatttccaaggagacgg GACGCAGGTCAATAGGTG
<--- 16
Y E S K G S S A V A D D S K L R P V I H
| | | | | | |
19 --->
721 TG gcagctgatcggtgcgatgtgcatgaacgactct
ACAGCGCGTCCACAACCAGCATGCCGCGTCGACTAGCCACGC
<--- 18
C R A G V G R T A Q L I G A M C M N D S
| | | | | | |
21 --->
781 cgtaactctcagctctctgtcgagga CCAGCGCAATGGT
gagtcgagagacagctcctgtaccaaagagtttacgcacaggtcgcgttacca
R N S Q L S V E D M V S Q M R V Q R N G
| | | | | | |
841 ATTATGGTTCAGAAAGACGAACAGCTGGACGTTCTCATTAAACTGGC
taatacc CCTGCAAGAGTAATTTGACCGCCTTCCGGTCCCG
<--- 20
I M V Q K D E Q L D V L I K L A E G Q G
| | | | | | |
901
GCAGGCGACGACTTGAGAATT
<--- 22
R P L L N S X
----------------------------------------------------------------
Frequency Range Number of Codons
-------------------------------------
0% - 4% 0
5% - 9% 4
10% - 14% 7
15% - 19% 18
20% - 24% 12
25% - 29% 13
30% - 34% 44
35% - 39% 19
40% - 44% 3
45% - 49% 3
>= 50% 184
-------------------------------------
Total Codons Used = 307
Tm Range # of Overlaps
-------------------------------------
<59 0
59 0
60 0
61 10
62 11
63 0
64 0
65 0
66 0
>=67 0
-------------------------------------
Tm Range = 1.9
Ovrlap Len Range # of Oligos
-------------------------------------
<15 1
15 0
16 2
17 4
18 2
19 3
20 5
21 2
22 2
23 0
24 0
>=25 0
-------------------------------------
Lowest Overlap = 14
Length Range # of Oligos
-------------------------------------
<51 0
51-52 0
53-54 0
55-56 1
57-58 0
59-60 21
61-62 0
63-64 0
65-66 0
67-68 0
69-70 0
>=71 0
-------------------------------------
Longest = 60
22 oligonucleotides need to be synthesized
----------------------------------------------------------------
1 ATGCGCGAACGCCCACACACCTCTGGTCACCACGGTGCCGGCGAAGCTCGCGCAACCGC 59
2 CAGTTCGGCACGAGCCTCCGGACCGTATGGGGAAACGGTAGAAGGCGCGGTTGCGCGAGC 60
3 AGGCTCGTGCCGAACTGTCTTCTCGTCTGACCACCCTGCGTAATACCCTGGCACCAGCAA 60
4 AGTTTTTCACCACCACATGCTTGCAGGTAACGCGGGTCGTTGGTTGCTGGTGCCAGGGTA 60
5 GCATGTGGTGGTGAAAAACTCAACCGCTTCCGTGACATCCAATGCCGTCGTCAGACCGCA 60
6 GTGTTACCAACCTGGATGTAGTTCGCGTTCAGATCCGCACGAACTGCGGTCTGACGACGG 60
7 ACTACATCCAGGTTGGTAACACTCGCACCATCGCCTGCCAGTACCCGCTGCAGTCTCAAC 60
8 ACCGGGGTACGGTTTTCAGCCAGCATGCGGAAGTGAGATTCCAGTTGAGACTGCAGCGGG 60
9 TGAAAACCGTACCCCGGTTCTGGCTGTGCTGGCGTCTTCTTCTGAGATCGCGAATCAGCG 60
10 CGTAGGTACCAGATTGACGGAAGTAGTCCGGCATACCGAAACGCTGATTCGCGATCTCAG 60
11 CCGTCAATCTGGTACCTACGGTTCTATCACCGTTGAATCCAAAATGACCCAGCAGGTCGG 60
12 GATGGTCAGGGTGTACATGTCCGCCATGATACCGTCACCCAGACCGACCTGCTGGGTCAT 60
13 GACATGTACACCCTGACCATCCGTGAAGCGGGTCAGAAAACCATCTCTGTTCCGGTTGTT 60
14 CGCTAGAAACGGCGGTTTGATCCGGCCAGTTACCGACGTGAACAACCGGAACAGAGATGG 60
15 AAACCGCCGTTTCTAGCGAGGTCACTAAAGCGCTCGCTTCTCTGGTTGATCAGACTGCGG 60
16 GGCAGAGGAACCTTTAGATTCATACATGTTACGTTTGGTCTCCGCAGTCTGATCAACCAG 60
17 TGAATCTAAAGGTTCCTCTGCCGTTGCGGACGACTCCAAACTGCGTCCAGTTATCCACTG 60
18 CGCACCGATCAGCTGCGCCGTACGACCAACACCTGCGCGACAGTGGATAACTGGACGCAG 60
19 GCAGCTGATCGGTGCGATGTGCATGAACGACTCTCGTAACTCTCAGCTCTCTGTCGAGGA 60
20 CCATAATACCATTGCGCTGGACACGCATTTGAGAAACCATGTCCTCGACAGAGAGCTGAG 60
21 CCAGCGCAATGGTATTATGGTTCAGAAAGACGAACAGCTGGACGTTCTCATTAAACTGGC 60
22 TTAAGAGTTCAGCAGCGGACGGCCCTGGCCTTCCGCCAGTTTAATGAGAACGTCC 55
FINAL SUMMARY FOR 1 SOLUTION
--------------------------------------------------------------------------------
# Tm Len | Score TmRange Short Long #Olig #Repeat #Misprime
1 62 60 | 0.000 1.9 14 60 22 0 0
--------------------------------------------------------------------------------
PCR Overlap
Lane 1: skipped
Lane 2: 100 bp Ladder
Lane 3: Primary (1°) PCR Primer - YopH
Lane 4: Secondary (2°) PCR Primer - YopH
- Nanodrop Graph of PCR² Primer with Yersinia pestis (YopH)
Week 5
Virtual Screening Refresher
- Table of Top 11 Ligands
Top 10 Ligands Images
- BindingDB_50228029, #1 best ligand
- 5193911, #2 best ligand
- 5157370, #3 best ligand
- 5185261, #4 best ligand
- 5224221, #5 best ligand
- 5143470, #6 best ligand
- 5109057, #7 best ligand
- 5186972, #8 best ligand
- 5230391, #9 best ligand
- 5159193, #10 best ligand
Top 3 Ligands
ID: BindingDB_50228029
Mol. Weight: 610.719343
Molecular Formula: C30H31FN4O5S2
Mol. Name: 3-fluoro-N-[1-[5-(4-phenylbutyl)-1H-imidazol-2-yl]-2-[4-(1,1,3-trioxo-1,
2-thiazolidin-5-yl)phenyl]ethyl]benzenesulfonamide
hDon: 3
hAcc: 7
Week 4
PCR pNIC-Bsa4 Gel Run
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pNIC-Bsa4 (Highest Conc. of pLIC)
Lane 4: PCR pNIC-Bsa4 (Medium Conc. of pLIC)
Lane 5: PCR pNIC-Bsa4 (Lowest Conc. of pLIC)
Lane 6: PCR pNIC-Bsa4 (No pLIC; Control)
PyMol Refresher
- View of the chains, active sites,and polar contacts in 2H2Q
- View of the chains, active sites,and polar contacts in 3CL9
- View of the chains, active sites,and polar contacts in 1U72
- Combination of the active sites for 1U72 & 3CL9, showing each of their polar contacts
- Four different chains involved in the protein 3HBB
- Comparison of both NAP (MTX) for the 1st chain in 3HBB
Week 3
Submitting DNA Sequence
Forward Reaction
NNNNNNNNNNNNNNNNNNNNNNNNANTGGGCNNGNCGTCNCATGCTCCCGGCCGCCNTGGCCGCGGNNTTTTAGTGANGNTNNNGGNGNNGACCNNNAATGATTCTNATTGNTTGANGGATAANTNNNNNGNNTGNGATCGTTAANCNNNNGNCCNANANGGNTTNTNNGGGAGGCACNNNNAATGCACACTACTTTNANGGCCAAGGCNATGGAAAACGAANNCCTTANGAGGGGGANNANAGGGCAAAGCTNACTGNCACCNANGGTGGACCTCTGCCNTTTGCTTGGGATATTTNATCACCACTGNCTCNANACNGAANCATACNATTNACCNGNNNNCCNGAATACATCCCTGANNATGTAAANCANTCATTCCCTGAGGGATANACATGGGAGAGGATCATGAACTTNNNANATNGNNNGGNGTGTACTGTCNNCNATGATNNCAGNATCNGANGAAACTGNTTNNTCTACNNNNNNCANTNTCNNAAAGTGAANTTTCCNCCCCNTGNACNTGNTATGCNGAAAAANANATNNGCCTGNNAACAANANNNNNANANNCTCNNTNCGNTGGATGNCANGNTCAGCTGAAACNACTTNNNGNNTCTNAAGTTGNNNNNANGTGGTTACAATNTNNGTGAATNNNCTTCTACTGNTGAGCATGNANGNCNGNGNGGACGCNNGGNANANNNNNTNNCCCTCACACTGNNNGTANCCANGCNCGNCNAGGATTNAANATTCGTNGANNNATNNNTAAATATCCNNTGNACGCCGCTCNTNCNNNNTCANCTNCATNNNCATCTNTAAAANNTCNNNANGNNTGNNNNGTCNGGNANCATGNNNNNCNGGNCCAANTCNNGCTCNNNNNGANNNNNANNNNNNNNTTCCTTGGGCCACCGGTTTTCNANNNNNNNNNTNNNNNAAAACTTCGANTTTCCNNNNNATTGNCNANNNNNNTCGTCCCCCNTTCCCNNCNTNGNNNNNNAAN
- Blast made through Nucleotides
Reverse Reaction
NNNNNNNNNNNGGTGANCTATAGAATACTCAAGCTATGCATCCNACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCACTAGTGATTTTGATTGATTGAAGGAGAAATATCATGAGTGTGATCGCTAAACAAATGACCTACAAGGTTTATATGTCAGGCACGGTCAATGGACACTACTTTGAGGTCGAAGGCGATGGAAAAGGAAAGCCTTACGAGGGGGAGCAGACGGTAAAGCTCACTGTCACCAAGGGTGGACCTCTGCCATTTGCTTGGGATATTTTATCACCACTGTCTCAATACGGAAGCATACCATTCACCAAGTACCCTGAAGACATCCCTGATTATGTAAAGCAGTCATTCCCTGAGGGATATACATGGGAGAGGATCATGAACTTTGAAGATGGTGCAGTGTGTACTGTCAGCAATGATTCCAGCATCCAAGGCAACTGTTTCATCTACAATGTCAAAATCTCTGGTGTGAACTTTCCTCCCAATGGACCTGTTATGCAGAAGAAGACACAGGGCTGGGAACCCAACACTGAGCGTCTCTTTGCACGAGATGGAATGCTGATAGGAAACAACTTTATGGCTCTGAAGTTGGAAGGAGGTGGTTACTATTTGTGTGAATTCAAATCTACTTACAAGGCAAAGAAGCCTGTGAGGATGCCAGGGTATCACTATGTTGACCGCAAACTGGATGTAACCAGTCACAACAAGGATTACACATTTGTTGAGCAGTGTGAAATATCCATTGCACGCCACTCTTTGCTCGGTCATCACCATCACCATCACTAAAATCCCGCGGCCATGGCGGCCGGGAGCATGCGACGTCGGGCCCAATTCGCCCTATAGTGAGTCGTATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGNGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGANGCCCGCACCGATCGCCNTTCCCANCAGTTGCGCAGCCTGNATGGNGAATGGNCNCNNCCNGNANNGNNCATNAGCGCGNNNNNNNNNNNNCNNNCAGNNNNACGCTANNNTTNCNNCNCNANCNNCGNNCTTNNGNTTNNNNNNTTTNNNNCNNNNTNNCNNTTTCCNTCAGNNNNNNNNGGGNNNNNNTNNNNCNANTNNNNTNNNNNNNNNCNNNNNNNNNNNNGGNNNNNNGNNNNNCNNNNNNNNNNNNNNN
- Human Blast
- Nucleotide Blast
Week 2
Restriction Enzyme Digest
Lane 1: Skipped
Lane 2: 1 kb Ladder
Lane 3: Uncut pGBR-22
Lane 4: EcoRI, cut with pGBR-22 (Tube A)
Lane 5: PvuII, cut with pGBR-22 (Tube B)
Lane 6: EcoRI + PvuII, cut with pGBR-22 (Tube C)
PCR pGBR22 Gel Run
1st Attempt:
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pGBR-22 (Tube A), none shown
Lane 4: PCR pGBR-22 (Tube B), none shown
Lane 5: PCR pGBR-22 (Tube C), none shown
Lane 6: PCR pGBR-22 (Tube D), none shown
2nd Attempt:
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pGBR-22 (Tube A), none shown
Lane 4: PCR pGBR-22 (Tube B), none shown
Lane 5: PCR pGBR-22 (Tube C), none shown
Lane 6: PCR pGBR-22 (Tube D), none shown
3rd Attempt:
Lane 1: Skipped
Lane 2: 100 bp Ladder
Lane 3: PCR pGBR-22 (Tube A)
Lane 4: PCR pGBR-22 (Tube B)
Lane 5: PCR pGBR-22 (Tube C)
Lane 6: PCR pGBR-22 (Tube D)
Week 1
Analyzing DNA Sequence
VDS4_M13R.. Original Sequence:
`NNNNNNNNNNNTATNGNATACTCAAGCTATGCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCACTAGTGATTTTGATTGATTGAAGGAGAAATATCATGAGTGTGATCGCTAAACAAATGACCTACAAGGTTTATATGTCAGGCACGGTCAATGGACACTACTTTGAGGTCGAAGGCGATGGAAAAGGAAAGCCTTACGAGGGGGAGCAGACGGTAAAGCTCACTGTCACCAAGGGTGGACCTCTGCCATTTGCTTGGGATATTTTATCACCACTGTCTCAATACGGAAGCATACCATTCACCAAGTACCCTGAAGACATCCCTGATTATGTAAAGCAGTCATTCCCTGAGGGATATACATGGGAGAGGATCATGAACTTTGAAGATGGTGCAGTGTGTACTGTCAGCAATGATTCCAGCATCCAAGGCAACTGTTTCATCTACAATGTCAAAATCTCTGGTGTGAACTTTCCTCCCAATGGACCTGTTATGCAGAAGAAGACACAGGGCTGGGAACCCAACACTGAGCGTCTCTTTGCACGAGATGGAATGCTGATAGGAAACAACTTTATGGCTCTGAAGTTGGAAGGAGGTGGTTACTATTTGTGTGAATTCAAATCTACTTACAAGGCAAAGAAGCCTGTGAGGATGCCAGGGTATCACTATGTTGACCGCAAACTGGATGTAACCAGTCACAACAAGGATTACACATTTGTTGAGCAGTGTGAAATATCCATTGCACGCCACTCTTTGCTCGGTCATCACCATCACCATCACTAAAATCCCGCGGCCATGGCGGCCGGGAGCATGCGACGTCGGGCCCAATTCGCCCTATAGTGAGTCGTATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAANAGGCCCGCACCGATCGCCCTTCCCACAGTTGCGCAGCCTGATGGCNATGGACGCNNCCTGNANCGNCGCATTAGCNCGGCNGGNNNGNGNNCNCGCAGCGNGACNCTACANTTNCNGCNNCNANCNNNNNCNTTCNNTTNTNCNNNTNNNNNNNNNNNNNNNTTNCCGNNAGNTNNAANNGGGGNNNNNNNNNATNNGNTNNNNNNNNNNCCAAANTGNNNGNNNNGNNNNNNNNGNNNNNNNNNNNNNNNNNNNNNNNGANCNNNNNNNNNNNNANNNNNNNNNNNCNNNNNAANNNNNCCNNTNNN
VDS_M13R.. Without the N’s:
TATNGNATACTCAAGCTATGCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCACTAGTGATTTTGATTGATTGAAGGAGAAATATCATGAGTGTGATCGCTAAACAAATGACCTACAAGGTTTATATGTCAGGCACGGTCAATGGACACTACTTTGAGGTCGAAGGCGATGGAAAAGGAAAGCCTTACGAGGGGGAGCAGACGGTAAAGCTCACTGTCACCAAGGGTGGACCTCTGCCATTTGCTTGGGATATTTTATCACCACTGTCTCAATACGGAAGCATACCATTCACCAAGTACCCTGAAGACATCCCTGATTATGTAAAGCAGTCATTCCCTGAGGGATATACATGGGAGAGGATCATGAACTTTGAAGATGGTGCAGTGTGTACTGTCAGCAATGATTCCAGCATCCAAGGCAACTGTTTCATCTACAATGTCAAAATCTCTGGTGTGAACTTTCCTCCCAATGGACCTGTTATGCAGAAGAAGACACAGGGCTGGGAACCCAACACTGAGCGTCTCTTTGCACGAGATGGAATGCTGATAGGAAACAACTTTATGGCTCTGAAGTTGGAAGGAGGTGGTTACTATTTGTGTGAATTCAAATCTACTTACAAGGCAAAGAAGCCTGTGAGGATGCCAGGGTATCACTATGTTGACCGCAAACTGGATGTAACCAGTCACAACAAGGATTACACATTTGTTGAGCAGTGTGAAATATCCATTGCACGCCACTCTTTGCTCGGTCATCACCATCACCATCACTAAAATCCCGCGGCCATGGCGGCCGGGAGCATGCGACGTCGGGCCCAATTCGCCCTATAGTGAGTCGTATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAANAGGCCCGCACCGATCGCCCTTCCCACAGTTGCGCAGCCTGATGGCNATGGACGCNNCCTGNANCGNCGCATTAGCNCGGCNGGNNNGNGNNCNCGCAGCGNGACNCTACANTTNCNGCNNCNANCNNNNNCNTTCNNTTNTNCNNNT
Blast #1:
Blast #2:
Comparison to Known DNA:
Translation with the PurpleProteinCodingSequenceforBB.txt:
>rf 1 UntitledMSVIAKQMTYKVYMSGTVNGHYFEVEGDGKGKPYEGEQTVKLTVTKGGPLPFAWDILSPLSQYGSIPFTKYPEDIPDYVKQSFPEGYTWERIMNFEDGAVCTVSNDSSIQGNCFIYNVKISGVNFPPNGPVMQKKTQGWEPNTERLFARDGMLIGNNFMALKLEGGGYYLCEFKSTYKAKKPVRMPGYHYVDRKLDVTSHNKDYTFVEQCEISIARHSLLGHHHHHH* ORF: >1c1|Sequence 1 ORF:105...788 Frame +3ATGAGTGTGATCGCTAAACAAATGACCTACAAGGTTTATATGTCAGGCACGGTCAATGGACACTACTTTGAGGTCGAAGGCGATGGAAAAGGAAAGCCTTACGAGGGGGAGCAGACGGTAAAGCTCACTGTCACCAAGGGTGGACCTCTGCCATTTGCTTGGGATATTTTATCACCACTGTCTCAATACGGAAGCATACCATTCACCAAGTACCCTGAAGACATCCCTGATTATGTAAAGCAGTCATTCCCTGAGGGATATACATGGGAGAGGATCATGAACTTTGAAGATGGTGCAGTGTGTACTGTCAGCAATGATTCCAGCATCCAAGGCAACTGTTTCATCTACAATGTCAAAATCTCTGGTGTGAACTTTCCTCCCAATGGACCTGTTATGCAGAAGAAGACACAGGGCTGGGAACCCAACACTGAGCGTCTCTTTGCACGAGATGGAATGCTGATAGGAAACAACTTTATGGCTCTGAAGTTGGAAGGAGGTGGTTACTATTTGTGTGAATTCAAATCTACTTACAAGGCAAAGAAGCCTGTGAGGATGCCAGGGTATCACTATGTTGACCGCAAACTGGATGTAACCAGTCACAACAAGGATTACACATTTGTTGAGCAGTGTGAAATATCCATTGCACGCCACTCTTTGCTCGGTCATCACCATCACCATCACTAA
Compare Protein Tranlsations:
Lost In Translation:
Translation 1:
>rf 1 UntitledXXXXXXYSSYASNALGALPYGRPAGGRTSDFD*LKEKYHECDR*TNDLQGLYVRHGQWTLL*GRRRWKRKALRGGADGKAHCHQGWTSAICLGYFITTVSIRKHTIHQVP*RHP*LCKAVIP*GIYMGEDHEL*RWCSVYCQQ*FQHPRQLFHLQCQNLWCELSSQWTCYAEEDTGLGTQH*ASLCTRWNADRKQLYGSEVGRRWLLFV*IQIYLQGKEACEDARVSLC*PQTGCNQSQQGLHIC*AV*NIHCTPLFARSSPSPSLKSRGHGGREHATSGPIRPIVSRITIHWPSFYNVVTGKTLALPNLIALQHIPLSPAGVIAXRPAPIALPTVAQPDGXGRXLXRRISXAGXXXRSXTLXXXXXXXXFXXXXXXXXXXPXXXXGXXXXXXXXXPXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPX
Translation 2:
>rf 2 UntitledXXXXXXTQAMHPTRWELSHMVDLQAAALVILID*RRNIMSVIAKQMTYKVYMSGTVNGHYFEVEGDGKGKPYEGEQTVKLTVTKGGPLPFAWDILSPLSQYGSIPFTKYPEDIPDYVKQSFPEGYTWERIMNFEDGAVCTVSNDSSIQGNCFIYNVKISGVNFPPNGPVMQKKTQGWEPNTERLFARDGMLIGNNFMALKLEGGGYYLCEFKSTYKAKKPVRMPGYHYVDRKLDVTSHNKDYTFVEQCEISIARHSLLGHHHHHH*NPAAMAAGSMRRRAQFALVVLQFTGRRFTTS*LGKPWRYPT*SPCSTSPFRQLARXGPHRSPFPQLRSLMAMDAXXXXALARXXXXXAAXXYXXXXXXXXSXXXXXXXXXXRXXXXGXXXXXXXXXQXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Translation 3:
>rf 3 UntitledXXXYXILKLCIQRVGSSPIWSTCRRPHF*LIEGEIS*V*SLNK*PTRFICQARSMDTTLRSKAMEKESLTRGSRR*SSLSPRVDLCHLLGIFYHHCLNTEAYHSPSTLKTSLIM*SSHSLRDIHGRGS*TLKMVQCVLSAMIPASKATVSSTMSKSLV*TFLPMDLLCRRRHRAGNPTLSVSLHEMECETTLWL*SWKEVVTICVNSNLLTRQRSL*GCQGITMLTANWM*PVTTRITHLLSSVKYPLHATLCSVITITITKIPRPWRPGACDVGPNSPYSESYYNSLAVVLQRRDWENPGVTQLNRLAAHPPFASWRNSEXARTDRPSHSCAA*WXWTXPXXXH*XGXXXXXQRDXTXXAXXXXXXXXXXXXXXXXXXXXXGXXXXXXXXXKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Translation with the PurpleProteinCodingSequenceforBB.txt:
>rf 1 UntitledMSVIAKQMTYKVYMSGTVNGHYFEVEGDGKGKPYEGEQTVKLTVTKGGPLPFAWDILSPLSQYGSIPFTKYPEDIPDYVKQSFPEGYTWERIMNFEDGAVCTVSNDSSIQGNCFIYNVKISGVNFPPNGPVMQKKTQGWEPNTERLFARDGMLIGNNFMALKLEGGGYYLCEFKSTYKAKKPVRMPGYHYVDRKLDVTSHNKDYTFVEQCEISIARHSLLGHHHHHH* ORF: >1c1|Sequence 1 ORF:105...788 Frame +3ATGAGTGTGATCGCTAAACAAATGACCTACAAGGTTTATATGTCAGGCACGGTCAATGGACACTACTTTGAGGTCGAAGGCGATGGAAAAGGAAAGCCTTACGAGGGGGAGCAGACGGTAAAGCTCACTGTCACCAAGGGTGGACCTCTGCCATTTGCTTGGGATATTTTATCACCACTGTCTCAATACGGAAGCATACCATTCACCAAGTACCCTGAAGACATCCCTGATTATGTAAAGCAGTCATTCCCTGAGGGATATACATGGGAGAGGATCATGAACTTTGAAGATGGTGCAGTGTGTACTGTCAGCAATGATTCCAGCATCCAAGGCAACTGTTTCATCTACAATGTCAAAATCTCTGGTGTGAACTTTCCTCCCAATGGACCTGTTATGCAGAAGAAGACACAGGGCTGGGAACCCAACACTGAGCGTCTCTTTGCACGAGATGGAATGCTGATAGGAAACAACTTTATGGCTCTGAAGTTGGAAGGAGGTGGTTACTATTTGTGTGAATTCAAATCTACTTACAAGGCAAAGAAGCCTGTGAGGATGCCAGGGTATCACTATGTTGACCGCAAACTGGATGTAACCAGTCACAACAAGGATTACACATTTGTTGAGCAGTGTGAAATATCCATTGCACGCCACTCTTTGCTCGGTCATCACCATCACCATCACTAA
Slicing & Dicing
- DNA cut with only EcoRI
- DNA cut with only PvuII
- DNA cut with both EcoRI & PvuII
Virtual Gel